Preferred Label : Bevacizumab/Cyclophosphamide/Pembrolizumab Regimen;
NCIt synonyms : Avastin/Cyclophosphamide/Keytruda; Bevacizumab/Oral Cyclophosphamide/Pembrolizumab; Oral Cyclophosphamide/Bevacizumab/Pembrolizumab; Oral Cyclophosphamide Plus Bevacizumab Plus Pembrolizumab; Bevacizumab-Cyclophosphamide-Pembrolizumab; Bevacizumab/Cyclophosphamide/Pembrolizumab;
NCIt definition : A regimen consisting of bevacizumab, oral cyclophosphamide and pembrolizumab that
can be used for the treatment of ovarian, fallopian tube, and primary peritoneal cancers.;
NCI Metathesaurus CUI : CL1927602;
Origin ID : C205404;
chemotherapy_regimen_has_component
concept_is_in_subset